Location History:
- Co. Dublin, IE (1997)
- Dublin, IE (1998)
Company Filing History:
Years Active: 1997-1998
Title: David John McConnell: Innovator in Gene Expression and Lipase Production
Introduction
David John McConnell is a notable inventor based in Dublin, Ireland. He has made significant contributions to the fields of gene expression and enzyme production. With a total of 2 patents, McConnell's work has the potential to impact various biotechnological applications.
Latest Patents
One of McConnell's latest patents is a gene expression system. This invention relates to an expression system that comprises a phage-like bacteriocin, known as 'phibacin', or a mutant thereof. It also includes a gene or mutant of a phibacin that has a function in gene expression, such as a repressor gene. This system is utilized to transform bacterial hosts for the production of proteins, particularly in gram-positive bacteria. Another significant patent is a process for preparing lipases. This process involves producing an active lipase enzyme in vitro by mixing an inactive or partly active lipase enzyme with a chaperone molecule. The mixture is then subjected to denaturation followed by renaturation to yield the active lipase enzyme.
Career Highlights
David John McConnell is currently associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk focuses on innovative solutions in biotechnology and pharmaceuticals.
Collaborations
Some of McConnell's notable coworkers include Kevin Martin Devine and Charles O'Kane. Their collaborative efforts contribute to the advancement of research and development in their respective fields.
Conclusion
David John McConnell is a distinguished inventor whose work in gene expression and enzyme production showcases his innovative spirit. His contributions have the potential to drive advancements in biotechnology and improve various applications in the industry.